Investigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver disease

Projektinformationen

EDC-MASLD

ID Finanzhilfevereinbarung: 101136259

DOI

10.3030/101136259

EK-Unterschriftsdatum 10 November 2023

Startdatum 1 Januar 2024

Enddatum 31 Dezember 2028

Finanziert unter

• Health

Gesamtkosten

€ 7 053 942,75

EU-Beitrag

€ 7 053 942,75

Koordiniert durch

OREBRO UNIVERSITY
Sweden

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Documents, reports (11)

D7.4 Cluster common Data Management Plan

DMP

D3.1 Survey of available data from clinical cohorts

Report on data already available from European NAFLD Registry and collaborative cohorts

D4.2 Initial assessment of chemical exposures European NAFLD Registry

Assessment of chemical exposures in samples with existing omics data from the European NAFLD Registry

D7.6 Scientific strategy of the cluster

Scientific strategy of the cluster

D7.2 Cluster web portal and visual identity

Cluster web portal and visual identity

D7.1 Common cluster dissemination and communication strategy

Strategy document for the communication and dissemination messages and activities of the cluster

D8.2 Project website and corporate design

Website, EDC-MASLD brand, and templates established

D7.5 Policy strategy of the cluster

Policy strategy of the cluster

D7.7 Cluster newsletter

Cluster newsletter

D7.3 Cluster brochure

Cluster brochure

D8.1 Dissemination and exploitation plan

Strategy document for the dissemination and exploitation, including communication activities.

Veröffentlichungen

Peer reviewed articles (2)

Metabolic and phenotypic changes induced by PFAS exposure in two human hepatocyte cell models

Autoren: Andi Alijagic, Lisanna Sinisalu, Daniel Duberg, Oleksandr Kotlyar, Nikolai Scherbak, Magnus Engwall, Matej Orešič, Tuulia Hyötyläinen
Veröffentlicht in: Environment International, Ausgabe 190, 2024, ISSN 0160-4120
Herausgeber: Elsevier BV
DOI: 10.1016/J.ENVINT.2024.108820

Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies

Autoren: Eleonora Dileo, Francesca Saba, Mirko Parasiliti-Caprino, Chiara Rosso, Elisabetta Bugianesi
Veröffentlicht in: Nutrients, Ausgabe 17, 2025, ISSN 2072-6643
Herausgeber: MDPI AG
DOI: 10.3390/nu17030477